Search Results - "Jardillier, J"

Refine Results
  1. 1

    Multicellular resistance: a paradigm for clinical resistance? by Desoize, Bernard, Jardillier, Jean-Claude

    Published in Critical reviews in oncology/hematology (01-11-2000)
    “…Research on resistance to cancer treatment was mainly focused for 20 years on multidrug resistance (MDR). No useful method of reversing MDR, suitable for…”
    Get full text
    Journal Article
  2. 2

    The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II by Larsen, A K, Grondard, L, Couprie, J, Desoize, B, Comoe, L, Jardillier, J C, Riou, J F

    Published in Biochemical pharmacology (19-10-1993)
    “…The antileukemic alkaloid, fagaronine, is a potent differentiation inducer of various hematopoietic cell lines. We show here that fagaronine is a DNA base-pair…”
    Get more information
    Journal Article
  3. 3

    Confocal spectral imaging analysis of intracellular interactions of mitoxantrone at different phases of the cell cycle by Feofanov, A, Charonov, S, Fleury, F, Kudelina, I, Jardillier, J C, Nabiev, I

    Published in Anticancer research (01-11-1999)
    “…It is suggested that the cytotoxicity of anticancer agent mitoxantrone (MITOX) is related to a complex combination of molecular interactions which lead to…”
    Get more information
    Journal Article
  4. 4

    Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells by WARREN, L, JARDILLIER, J. C, ORDENTLICH, P

    Published in Cancer research (Chicago, Ill.) (15-04-1991)
    “…The multiple drug-resistant human lymphoblastic leukemic cell, CEM/VLB100, in which P-glycoprotein (P-170) is overexpressed, has a lowered content of lysosomal…”
    Get full text
    Journal Article
  5. 5

    Piperazine derivatives of butyric acid as differentiating agents in human leukemic cells by GILLET, R, JEANNESSON, P, SEFRAOUI, H, ARNOULD-GUERIN, M.-L, KIRKIACHARIAN, S, JARDILLIER, J.-C, PIERI, F

    “…Butyric acid is a potent antineoplastic agent with a well-documented differentiation activity on a wide variety of tumor cells. However, its clinical…”
    Get full text
    Journal Article
  6. 6

    Molecular determinants of site-specific inhibition of human DNA topoisomerase I by fagaronine and ethoxidine. Relation to DNA binding by Fleury, F, Sukhanova, A, Ianoul, A, Devy, J, Kudelina, I, Duval, O, Alix, A J, Jardillier, J C, Nabiev, I

    Published in The Journal of biological chemistry (04-02-2000)
    “…DNA topoisomerase (top) I inhibition activity of the natural alkaloid fagaronine (NSC157995) and its new synthetic derivative ethoxidine…”
    Get full text
    Journal Article
  7. 7

    Production and Activation of Matrix Metalloprotease-9 (MMP-9) by HL-60 Promyelocytic Leukemia Cells by Devy, Laetitia, Noël, Agnès, Baramova, Eugénia, Bajou, Khalid, Trentesaux, Chantal, Jardillier, Jean-Claude, Foidart, Jean-Michel, Jeannesson, Pierre

    “…Human promyelocytic HL-60 cells have been used as a model of acute leukemia to investigate the expression and the regulation of matrix metalloproteases (MMPs),…”
    Get full text
    Journal Article Web Resource
  8. 8

    Nuclear DNA content and chromatin texture in multidrug-resistant human leukemic cell lines by Dufer, J, Millot-Broglio, C, Oum'Hamed, Z, Liautaud-Roger, F, Joly, P, Desplaces, A, Jardillier, J C

    Published in International journal of cancer (03-01-1995)
    “…Nuclear morphological alterations associated with multidrug resistance (MDR) were evaluated by image cytometry in various human leukemic cell sub-lines: 3 cell…”
    Get more information
    Journal Article
  9. 9

    Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells by Morceau, Franck, Aries, Anne, Lahlil, Rachid, Devy, Laetitia, Jardillier, Jean-Claude, Jeannesson, Pierre, Trentesaux, Chantal

    Published in Biochemical pharmacology (22-03-1996)
    “…Human erythroleukemic K 562 cells were induced to differentiate along the erythroid lineage by anthracycline antitumor drugs, such as aclacinomycin (ACLA) and…”
    Get full text
    Journal Article
  10. 10

    Sequential overexpression of LRP and MRP but not P-gp 170 in VP16-selected A549 adenocarcinoma cells by Trussardi, A, Poitevin, G, Gorisse, M C, Faroux, M J, Bobichon, H, Delvincourt, C, Jardillier, J C

    Published in International journal of oncology (01-09-1998)
    “…Chemoresistance remains the major obstacle to successful therapy of lung cancer. In order to understand drug resistance mechanisms, the expression of three…”
    Get more information
    Journal Article
  11. 11

    Increased accumulation of drugs in multidrug-resistant cells induced by liposomes by WARREN, L, JARDILLIER, J.-C, MALARSKA, A, AKELI

    Published in Cancer research (Chicago, Ill.) (01-06-1992)
    “…A multidrug-resistant cell such as the human lymphoblastic leukemic cell CEM/VLB100 accumulates far less vinblastine (VLB) than its drug-sensitive parent, CEM…”
    Get full text
    Journal Article
  12. 12

    Expression, purification and DNA-cleavage activity of recombinant 68-kDa human topoisomerase I-target for antitumor drugs by Bronstein, I B, Wynne-Jones, A, Sukhanova, A, Fleury, F, Ianoul, A, Holden, J A, Alix, A J, Dodson, G G, Jardillier, J C, Nabiev, I, Wilkinson, A J

    Published in Anticancer research (01-01-1999)
    “…The gene encoding human DNA topoisomerase (topo) I, the target of numerous anticancer drugs, has been subcloned into bacterial, yeast and baculovirus-based…”
    Get more information
    Journal Article
  13. 13

    Human DNA topoisomerase I inhibitory activities of synthetic polyamines: relation to DNA aggregation by Sukhanova, Alyona, Dêvy, Jerome, Pluot, Michel, Bradley, Jean-Claude, Vigneron, Jean-Pierre, Jardillier, Jean-Claude, Lehn, Jean-Marie, Nabiev, Igor

    Published in Bioorganic & medicinal chemistry (01-05-2001)
    “…DNA aggregation by polyamines has acquired importance as a prerequisite for the cellular uptake of DNA for gene therapy. Intracellular polyamines are…”
    Get full text
    Journal Article
  14. 14

    Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells by ARIES, A, TRENTESAUX, C, OTTOLENGHI, S, JARDILLIER, J.-C, JEANNESSON, P, DOUBEIKOVSKI, A

    Published in Blood (01-04-1996)
    “…Anthracycline antitumor drugs such as aclacinomycin (ACM) and doxorubicin (DOX) used in subtoxic concentrations induce erythroid differentiation of the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Partial restoration of all trans retinoic acid (ATRA) sensitivity by compactin in ATRA-resistant leukemic cells (ATRA-R HL-60) by Gueddari, Naima, Madoulet, Claudie, Lefebvre, Philippe, Berthou, Laurence, Chomienne, Christine, Jardillier, Jean Claude

    Published in Leukemia research (01-06-2000)
    “…The resistance to all trans retinoic acid (ATRA) differentiating treatment is a consequence, in most of the cases, of either increased catabolism or down…”
    Get full text
    Journal Article
  17. 17

    Selective enhancement of Raman or fluorescence spectra of biomolecules using specifically annealed thick gold films by Strekal, Nathali, Maskevich, Alexandre, Maskevich, Sergey, Jardillier, Jean-Claude, Nabiev, Igor

    Published in BIOPOLYM (2000)
    “…Annealing of “thick” metal films deposited onto a smooth dielectric substrate leads to high‐order self‐organization of metal clusters on the film surface. This…”
    Get full text
    Journal Article
  18. 18

    Enhancement of all-trans-retinoic acid efficiency in granulocytic differentiation of HL-60 cells by incorporation into low density lipoprotein by Gueddari, N, Bobichon, H, Depierreux, C, Liautaud-Roger, F, Duriez, P, Dufer, J, Jardillier, J C

    Published in International journal of oncology (01-11-1998)
    “…All-trans-retinoic acid (ATRA) has been proven to lead to complete remission of acute promyelocytic leukemia by inducing differentiation into granulocytes…”
    Get more information
    Journal Article
  19. 19

    Expression of mdr1 gene in human breast primary tumors and metastases by HENNEQUIN, E, DELVINCOURT, C, POURNY, C, JARDILLIER, J.-C

    “…Expression of mdr1 gene has been evaluated in 34 tumor samples obtained from breast cancer patients who were classified according to their treatment, and…”
    Get full text
    Journal Article
  20. 20

    Study of sodium orthovanadate as a reverser of multidrug resistance on lymphoblastic leukemic CEM/VLB100 cells by Colin, M, Madoulet, C, Baccard, N, Arsac, F, Jardillier, J C

    Published in Anticancer research (01-11-1994)
    “…The occurrence of multidrug resistance (MDR) is the major cause of failure of cancer chemotherapy. Finding a way to circumvent this problem is now a major…”
    Get more information
    Journal Article